GitLab Inc., together with its subsidiaries, develops software for the software development lifecycle in the United States, Europe, and the Asia Pacific.
FAIL · Does not pass the screen
46.99 USD
At the last full screen 2026-09-11
Screened 2026-09-11 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markup label.
GitLab Inc. holds its Markup at $46.99. Consolidating, no directional conviction, held for 11 days.
As held on the ledger · 2026-09-11
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 11 days
Price at the screen
$46.99
Valuation
N/A trailing · 45.25 forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.99
The Workings
Five Screens, Shown in Full
Does not pass. Interest-bearing securities
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
0.01%
Below 33%
Interest-bearing debt is just 0.0% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
59.81%
Below 33%
Interest-bearing cash and securities are 59.8% of assets, above the one-third limit.
Fail
Receivables
30.99%
Below 49%
Money owed to the company is 31.0% of assets, under the 49% limit.
Pass
Revenue purity
4.78%
Below 5%
Only 4.8% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. The price runs 16.2% above the base estimate.
Third-party analyst targets: 23 covering, consensus Buy. The average target sits +17% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
GitLab Platform Wins Fans But Not Value
Picture a single workbench where coders, security teams and ops staff all reach for the same tools without switching tabs. GitLab built that workbench, and revenue keeps rising at 23 percent a year. Yet the shares sit 13 percent above our fair value, carry a forward multiple of 31.8 times, and still lose money on a negative 2 percent margin. We pass.
The market already prices in perfection, with twenty-three analysts clustered around a hold rating and a $32 target that matches the current price. Negative return on equity and an unknown moat leave little room for disappointment. Ethical screens are cleared, but that alone does not justify stretching for growth at any price.
Valuation risk sits front and centre. If growth slows or losses persist, the premium can compress quickly. Currency moves and competition from larger cloud suites add further pressure on margins that have yet to turn positive. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
GTLB trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-09-01Markup$41.66+0.0%Entry 12
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 42%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (23 analysts) rates it hold, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-31Markup$41.66+0.0%Entry 11
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 42%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (23 analysts) rates it hold, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-30Markup$41.66+0.0%Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 42%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (23 analysts) rates it hold, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-29Markup · changed$41.66+0.0%Entry 9
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 42%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (23 analysts) rates it hold, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-28Accumulation$41.66+0.0%Entry 8
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 42%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (23 analysts) rates it hold, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-27Accumulation$41.66+0.0%Entry 7
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 42%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (23 analysts) rates it hold, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-26Accumulation$41.66+6.9%Entry 6
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 42%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (23 analysts) rates it hold, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 19.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 42%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (23 analysts) rates it hold, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-31Markup$32.72+17.7%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 17.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 42%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (23 analysts) rates it hold, with a mean price target of $30. Insiders have been net buyers over the past quarter.
2026-07-18Markup$27.79+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 42%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (23 analysts) rates it hold, with a mean price target of $30.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
